Certmedica International GmbH   Report issue

For profit Phase 4
Founded: Aschaffenburg Germany (2005)
Status: No NME R&D (2005)

Organization Overview

First Clinical Trial
2009
NCT02529631
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Certmedica International GmbH

Active Ingredients

Drugs in Phase 4 Trials (3)

polyglucosamine (2 trials)

tartaric acid (1 trial)

vitamin c (1 trial)

Drugs in Other Trials (1)

orlistat (xenical) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Overweight (Phase 4)

Weight Loss (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 2
  • # of Trial APIs: 4